The journey towards personalized medicine in asthma: where are we now?

Evening Symposium
Chairs: R. Buhl (Mainz, Germany)
Aims: Organized by Novartis Pharma AG
Welcome and introduction
R. Buhl (Mainz, Germany)
Webcast
Webcast
In the era of personalized medicine, what are the current unmet needs in asthma?
J. FitzGerald (Vancouver (BC), Canada)
Webcast
Webcast
Inhaled therapies: can they breathe new life into asthma?
A. Woodcock (Manchester (Greater Manchester), United Kingdom)
Webcast
Webcast
The pathway to inflammation in asthma: the role of the DP2 receptor
O. Palomares (Madrid, Spain)
Webcast
Webcast
Anti-IgE therapy: current knowledge and future perspective
R. Buhl (Mainz, Germany)
Webcast
Webcast
Chair-led expert discussion and audience Q&A
R. Buhl (Mainz, Germany) J. FitzGerald (Vancouver (BC), Canada) A. Woodcock (Manchester (Greater Manchester), United Kingdom) O. Palomares (Madrid, Spain)
Webcast
Webcast
Summary and close
R. Buhl (Mainz, Germany)
No content made available
No content made available